Clinical validation of image-based AI predictive biomarkers for precision neoadjuvant triple-negative breast cancer treatment (PEAR-TNBC)

被引：0
|
作者：
Williams, Matthew
Peerani, Eleonora
Tham, Elli
Iori, Francesco
de Fraine, George Richard Tiger Bevan
Loughrey, Kerrie
Kaffa, Andreas Dimitri
Richardson, Thomas David Laurent
Liberal, Carolina
Velentza-Almpani, Angeliki
Wiskerke, Demi Annemarie
Sangkolah, Farah
Crawley, Aston Martin
Kearney, Jay
Molina, Edgar Giussepi Lopez
Bah, Nourdine Kabirou
Tasoulis, Marios Konstantinos
Kirwan, Cliona C.
Ranatunga, Duleek Nimantha Bandara
Hall, Peter Edward
机构：
[1] Ourotech Ltd T A Pear Bio, London, England
[2] Royal Marsden NHS Fdn Trust, London, England
[3] Manchester Univ Fdn Trust, Manchester, Lancs, England
[4] Barts Canc Ctr, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS627
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant treatments for triple-negative breast cancer (TNBC)
    von Minckwitz, G.
    Martin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 35 - 39
  • [2] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Cho, Eun Yoon
    Chang, Myung Hee
    Choi, Yoon La
    Lee, Jeong Eon
    Nam, Seok Jin
    Yang, Jung-Hyun
    Park, Yeon Hee
    Ahn, Jin Seok
    Im, Young-Hyuck
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 753 - 761
  • [3] Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
    Eun Yoon Cho
    Myung Hee Chang
    Yoon La Choi
    Jeong Eon Lee
    Seok Jin Nam
    Jung-Hyun Yang
    Yeon Hee Park
    Jin Seok Ahn
    Young-Hyuck Im
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 753 - 761
  • [4] Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple-negative breast cancer (TNBC).
    Krivorotko, Petr
    Zhiltsova, Elena
    Gigolaeva, Larisa
    Emelyanov, Alexander
    Pesotskiy, Roman
    Yerechshenko, Sergey
    Nikolaev, Kirill
    Komyahov, Alexander
    Ivanova, Olga
    Tabagua, Tengiz
    Zernov, Konstantin
    Ivanov, Vadim
    Aseeva, Zalina
    Bessonov, Alexander
    Semiglazov, Vladimir
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
    da Silva, Jesse Lopes
    Rodrigues, Fabiana Resende
    de Mesquita, Guilherme Gomes
    Fernandes, Priscila Valverde
    Santos Thuler, Luiz Claudio
    de Melo, Andreia Cristina
    BREAST CANCER-TARGETS AND THERAPY, 2021, 13 : 31 - 44
  • [6] Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
    Lee, Jieun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [7] Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
    Amos, Keith D.
    Adamo, Barbara
    Anders, Carey K.
    INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
  • [8] Deep dive in triple-negative breast cancer (TNBC) is a need in the era of precision medicine
    Bakri, H. M.
    Mohamed, R. F.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1399 - S1399
  • [9] The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
    Weng, Lijuan
    Zhou, Jianliang
    Guo, Shenchao
    Xu, Nong
    Ma, Ruishuang
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [10] Pembrolizumab in the neoadjuvant Treatment of early triple-negative Breast Cancer
    Dierks, Friederike
    Pietsch, Elisabeth
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (09) : 841 - 843
12345